![]() |
|
|
The Nutrition Research Program, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4
* To whom correspondence should be addressed. E-mail: sinnis{at}cw.bc.ca.
Cystic fibrosis (CF) is associated with many clinical complications including steatosis for which the relation to defective CF transmembrane conductance regulator protein is unclear. Choline deficiency results in hepatic steatosis. Choline is the precursor of betaine, which donates methyl groups for remethylation of homocysteine to methionine and dimethylglycine. Previously, we have shown phospholipid malabsorption and increased plasma homocysteine in children with CF. In these studies we used normal phase HPLC with tandem mass spectrometry to determine plasma choline, betaine, and dimethylglycine in children with CF (n = 34) and healthy control children without CF (n = 15). Plasma choline, betaine, and dimethylglycine were significantly lower in children with CF (means ± SEM, 6.48 ± 0.35, 23.8 ± 1.49, 1.49 ± 0.13 µmol/L, respectively) than in children without CF (8.98 ± 0.46, 37.3 ± 1.84, 3.01 ± 0.17 µmol/L, respectively). Plasma choline (r = 0.373, P = 0.007) and betaine (r = 0.399, P = 0.005) were positively related to methionine, and choline was inversely related to homocysteine (r = 0.316, P = 0.03). Choline, betaine, and dimethylglycine were all significantly and positively related to the plasma S-adenosylmethionine:S-adenosylhomocysteine (SAM:SAH) ratio (r = 0.294, r = 0.377, r = 0.442, respectively; P < 0.05). The plasma choline:betaine and betaine:dimethylglycine ratios did not differ between the children with CF and the control children, suggesting no increase in betaine synthesis, or betaine-dependent remethylation of homocysteine. These studies suggest that choline depletion may contribute to increased homocysteine in children with CF. Choline depletion and altered thiol metabolism may contribute to the clinical complications associated with CF.
This article has been cited by other articles:
![]() |
M. A. Caudill, N. Dellschaft, C. Solis, S. Hinkis, A. A. Ivanov, S. Nash-Barboza, K. E. Randall, B. Jackson, G. N. Solomita, and F. Vermeylen Choline Intake, Plasma Riboflavin, and the Phosphatidylethanolamine N-Methyltransferase G5465A Genotype Predict Plasma Homocysteine in Folate-Deplete Mexican-American Men with the Methylenetetrahydrofolate Reductase 677TT Genotype J. Nutr., April 1, 2009; 139(4): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Matthews, K. Lorent, R. Manoral-Mobias, Y. Huang, W. Gong, I. V. J. Murray, I. A. Blair, and M. Pack TNF{alpha}-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish s-adenosylhomocysteine hydrolase Development, March 1, 2009; 136(5): 865 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Veenema, C. Solis, R. Li, W. Wang, C. V Maletz, C. M Abratte, and M. A Caudill Adequate Intake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load Am. J. Clinical Nutrition, September 1, 2008; 88(3): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Friesen, E. M. Novak, D. Hasman, and S. M. Innis Relationship of Dimethylglycine, Choline, and Betaine with Oxoproline in Plasma of Pregnant Women and Their Newborn Infants J. Nutr., December 1, 2007; 137(12): 2641 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Innis, A G. F Davidson, S. Melynk, and S J. James Choline-related supplements improve abnormal plasma methionine-homocysteine metabolites and glutathione status in children with cystic fibrosis Am. J. Clinical Nutrition, March 1, 2007; 85(3): 702 - 708. [Abstract] [Full Text] [PDF] |
||||